DMC Global Reports First Quarter Financial Results
Apr 26, 2018 20:06 pm UTC| Business
First quarter sales of $67.3 million increased 24% sequentially and 73% from Q1 2017DynaEnergetics and NobelClad report sequential sales increases of 32% and 5%, respectivelyConsolidated gross margin improves to 34% from...
Financial Institutions, Inc. Announces First Quarter 2018 Results
Apr 26, 2018 20:06 pm UTC| Business
WARSAW, N.Y., April 26, 2018 -- Financial Institutions, Inc. (Nasdaq:FISI), today reported financial and operational results for the first quarter ended March 31, 2018. Financial Institutions, Inc. (the “Company”) is...
Vital Therapies Announces Upcoming First Quarter Financial Results Conference Call with Webcast
Apr 26, 2018 20:06 pm UTC| Business
SAN DIEGO, April 26, 2018 -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will release its first quarter...
ZAGG to Report First Quarter 2018 Results on May 8, 2018
Apr 26, 2018 20:06 pm UTC| Business
SALT LAKE CITY, April 26, 2018 -- ZAGG Inc (Nasdaq:ZAGG), a leading global mobile lifestyle company, will report first quarter financial results on Tuesday, May 8, 2018, immediately following the closing of regular...
First Hawaiian, Inc. Reports First Quarter 2018 Financial Results and Declares Dividend
Apr 26, 2018 20:06 pm UTC| Business
Net income of $68.0 million or $0.49 per diluted share and core net income1 of $68.3 million, or $0.49 per diluted share1.35% return on average total assets and 1.43% core return on average tangible assets111.02% return on...
CubeSmart Reports First Quarter 2018 Results
Apr 26, 2018 20:05 pm UTC| Business
MALVERN, Pa., April 26, 2018 -- CubeSmart (NYSE:CUBE) today announced its operating results for the three months ended March 31, 2018. “We are pleased with our first quarter results that reflect steady, broad-based...
Apr 26, 2018 20:05 pm UTC| Business
CAMBRIDGE, Mass. and LAS VEGAS, April 26, 2018 -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat people with serious and...